Surveillance of susceptibility of clinical isolates to gatifloxacin and various antimicrobial agents

Japanese Journal of Chemotherapy

Volumn 53, Issue 10, 2005, Pages 627-640

  Yamaguchi, Keizo ^a   Furuya, Nobuhiko ^a   Iwata, Morihiro ^b   Watanabe, Naoki ^c,d   Uehara, Nobuyuki ^d   Yasujima, Minoru ^e   Kasai, Takeshi ^f   Kaku, Mitsuo ^g   Abe, Yuko ^h   Igari, Jun ⁱ   Oguri, Toyoko ^j   Baba, Hisashi ^k   Yoshimura, Hitoshi ^l   Yamanaka, Kiyoharu ^m   Ischiyama, Satoshi ⁿ   Kusano, Nobuchika ^o   Murao, Naoko ^o   Ono, Junko ^p   Tou, Hiromi ^p   Okada, Kaoru ^q   Ishida, Masami ^q   Hirakata, Yoichi ^r   Matsuda, Junichi ^r   more..

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^e HIROSAKI UNIVERSITY   (Japan)

^f HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h TOHOKU UNIVERSITY HOSPITAL   (Japan)

ⁱ JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j JUNTENDO UNIVERSITY HOSPITAL   (Japan)

^k NAGOYA UNIVERSITY HOSPITAL   (Japan)

^l Mie Prefectural Shima Hospital   (Japan)

^m Otemae Hospital   (Japan)

ⁿ KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^o OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^p FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^q Kitakyushu Medical Center   (Japan)

^r NAGASAKI UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

Fluoroquinolone; Gatifloxacin; Surveillance

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFCAPENE; CEFDINIR; CEFDITOREN; CIPROFLOXACIN; CLARITHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MINOCYCLINE; QUINOLONE DERIVATIVE; SPARFLOXACIN; TELITHROMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PENICILLIN RESISTANCE; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE; URINALYSIS;

EID: 28444471310     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Schaeffer A J: The expanding role of fluoroquinolones. Dis Mon 49: 129-147, 2003
2. Keam S J, Croom K F, Keating G M: Gatifloxacin: a review of its use in the treatment of bacterial infections in the US. Drugs 65: 695-724, 2005
3. Chen F J, Lo H J: Molecular mechanisms of fluoroquinolone resistance. J Microbiol Immunol Infect 36: 1-9, 2003
4. Neu H C: Bacterial resistance to fluoroquinolones. Rev Infect Dis 10 (Suppl 1): S57-63, 1988
5. Giamarellou H: Activity of quinolones against gram-positive cocci: clinical features. Drugs 49 (Suppl 2): 58-66, 1995
6. Low D E, Azavedo J, Weiss K, et al: Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob Agents Chemother 46: 1295-1301, 2002
7. Chinese source. 2002 gatifloxacin 771-786, 2004
8. Manual of Clinical Microbiology 8th ed. ASM, 2003
9. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-sixth edition. M7-A6. Wayne, PA, 2003
10. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement M100-S14. Wayne, PA, 2004
11. Chinese source. gatifloxacin in vitro in vivo 47 (Suppl 2): 69-80, 1999
12. Ishida K, Kaku M, Irifune K, et al: In-vitro and in-vivo acitivity of a new quinolone AM-1155 against Mycoplasma pneumoniae. J Antimicrob Chemother 34: 875-883, 1994
13. Miyashita N, Niki Y, Kishimoto T, et al: In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob Agents Chemother 41: 1331-1334, 1997
14. Chinese source. gatifloxacin 47 (Suppl2): 57-68, 1999
15. Chinese source. Gatifloxacin 2002 Jpn J Antibiotic 55: 800-807, 2002
16. Iinuma Y, Inoue M, Farrell D: Longitudinal surveillance of antibiotic resistance among clinical isolates of community-acquired respiratory tract pathogens collected in Japan during the winters of 1999-2000 and 2000-2001, An annual meeting of the American Society for Microbiology, the 42nd ICAAC, California, 2002
17. Yokota S, Sato K, Kuwahara O: Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan. Antimicrob Agents Chemother 46: 3311-3315, 2002
18. Chinese source. 1 52 (Suppl A): 119, 2004
19. Jeff P, Allison M, Karen G, et al: In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother 48: 3305-3311, 2004
20. Chinese source. β (BLNAR) 9: 22-29, 1999
21. Fukuda H, Hori S, Hiramatsu. K: Antibacterial Activity of Gatifloxacin (AM-1155, CG5501, BMS-206584), a Newly Developed Fluoroquinolone, against Sequentially Acquired Quinolone-Resistant Mutants and the norA Transformant of Staphylococcus aureus. Antimicrob Agents Chemother 42: 1917-1922, 1998
22. Takei M, Fukuda H, Kishii R, et al: Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition. Antimicrob Agents Chemother 45: 3544-3547, 2001
23. Chinese source. 2002, 52 11,475 Jpn J Antibiotic 58: 17-44, 2005
24. Ishii J, Nakae T: Specific interaction of the protein-D2 porin of Pseudomonas aeruginosa with antibiotics. FEMS Microbiol Lett 136: 85-90, 1996
25. Gotoh N, Tsujimoto H, Tsuda M, et al: Characterization of the MexC-MexD-OprJ multidrug efflux system in ΔmexA-mexB-oprM mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 42: 1938-1943, 1998
26. Yoneyama H, Ocaktan A, Tsuda M, et al: The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa. Biochem Biophys Res Commun 233: 611-618, 1997
27. Chinese source. 48: 610-632, 2000
28. Wang M, Tran J H, Jacoby G A, et al: Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 47: 2242-2248, 2003
29. Wang M, Saham D F, Jacoby G A, et al: Emerging plasmid-mediated. quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 48: 1295-1299, 2004
30. Chinese source. 8 Jpn J Antibiotic 53: 409-421, 2000
31. Knapp J S, Fox K K, Trees D L, et al: Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg Infect Dis 3: 33-39, 1997
32. Zheng H P, Cao W L, Wu X Z, et al: Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996-2001. Sex Transm. Infect 79: 399-402, 2003
33. Heffernan H, Brokenshire M, Woodhouse R, et al: Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002. N Z Med J 117: U817, 2004
34. Yoo J, Yoo C, Cho Y, et al: Antimicrobial resistance patterns (1999-2002) and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea. Sex Transm Dis 31: 305-310, 2004
35. Tanaka M, Naito S, Nakayama H, et al: Antimicrobial susceptibility of Neisseria gonorrhoeae in Fukuoka city, Japan, in the early 1980s and 1997-1998: Emergence of high-level fluoroquinolone resistance. Antimicrob Agents Chemother 43: 722-723, 1999